FTSCI (Hubei) Science and Technology Co., Ltd.

Send message

  💬

FTSCI (Hubei) Science and Technology Co., Ltd.

(21799km)
Timing10-21
Telephone+8615792125904   ☎
AddressR303, Building C8,R&D Office Zone, Biomedical Park, East Lake High-Tech Development Zone in Gaoxin Avenue 858 Wuhan,China (use navigation at the top)
Websiteftscicom.1.tt   💻
Emailzhangjinjing@ftsci.com.cn

FTSCI (Hubei) Science and Technology Co., Ltd. was founded in 2014, the main business is the research and development, production and sales of high-purity reagents, is a national high-tech enterprise, Hubei academician expert workstation station unit, Hubei Province major scientific and technological research project joint undertaking unit, the only domestic LC-MS level high-purity solvent production enterprise.

The company focuses on the research and development of separation and purification, chiral drug molecular synthesis, trace detection and analysis technology, and has applied for more than 50 patents, including 2 US patents, and has authorized 21. Headquartered in the national incubator of Biomedical Park, East Lake High-tech Zone, Wuhan City, the production base is located in Hubei Yunmeng National Salt and Chemical Industrial Park. The main products are UPLC-MS, LC-MS, HPLC, anhydrating grade, preparative grade and Methyl Alcohol, liquid buffer salt additives, gas chromatography solvents, ion pair reagents, derivative reagents, auxiliary reagents for agricultural residues, etc. The company has built the "Hubei Province Ultra-clean and high-purity reagent Enterprise and School Joint Innovation Center", with more than 20 sets of Q-TOF LC-MS, UPLC, HPLC, spectrum and other equipment.

The company has always adhered to the concept of standardized management, and has passed the international authoritative SGS and NOA management system certification. Verton always adheres to the mission of "China New Purity", carries the vision of "building a world-class high-purity solvent brand", practices the values of "focus, sincerity, innovation and win-win", and follows the development strategy of "import substitution, new sales and biotechnology", based on improving the research and development system of high-purity biochemical products, establishing new sales channels and cooperation models, and developing emerging biopharmaceutical technologies.